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Abstract; 
Background; chronic obstructive pulmonary disease (COPD) leads to significant morbidity and poor quality of 
life among patients. This study was conducted to evaluate anemia among patients with COPD as there is no such 
study done in our population. Material and Methods: This Cross sectional study enrolled a total of 142 patients 
with COPD from Department of Medicine, Nishtar Hospital Multan. Three ml of venous blood sample was 
drawn and sent to Pathology Laboratory of the hospital for hemoglobin estimation to diagnose anemia. All the 
relevant information were noted on the proforma and data was analyzed by using computer program SPSS 
version 20. Results; Of these 142 study cases, 94 (66.2%) were male patients while 48 (33.8%) were female 
patients. Mean age of our study cases was 54.68 ± 6.47 years (with minimum age of our study cases was 35 
years while maximum age was 60 years). Fifty seven (40.1%) were rural while 85 (59.9%) had urban residential 
background, 116 (81.7%) were poor, 34 (23.9%) were diabetic and 31.7% were hypertensive. Our study results 
reported 87 (61.3 %) were normal weight, 33 (23.2 %) were overweight and 22 (15.5 %) were obese. Smoking 
was noted in 70 (49.3%) patients. Mean duration of illness was 26.32 ± 12.44 months and 92 (64.8%) had 
disease duration more than 18 months. Mean hemoglobin level of our patients was 11.14 ± 1.76 g/dL (Range; 
9.4 g/dL to 14.5 g/dL) and anemia was present in 64 (45.1%) patients.   
Conclusion; Very high frequency of anemia was noted in our study among patients having chronic obstructive 
pulmonary disease (COPD). Anemia was significantly associated with poor socio – economic status, obesity and 
prolonged disease duration. Clinicians who are treating these patients with COPD must check their hemoglobin 
levels regularly for better prognosis. 
Keywords; Chronic Obstructive pulmonary disease, anemia, frequency.   
 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.40, 2018 
 
45 
Introduction; 
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by a decline in 
lung function over time and accompanied by respiratory symptoms, primarily dyspnea, cough, and sputum 
production. Consequently, COPD is associated with a significant economic burden, including hospitalization, 
work absence, and disability. The severity of COPD can be determined and classified by different methods. 
Incidence and prevalence estimates differ greatly, depending on the methods used for diagnosis and 
classification. It is important to understand the true epidemiology of COPD to monitor trends over time and to 
determine the effectiveness of potential treatments or preventive measures 
1-3
.Chronic obstructive pulmonary 
disease (COPD) is now the third most common cause of death in the world 
4
. COPD is defined in terms of 
airflow obstruction and operationalised as a low ratio of forced expiratory volume in 1 s (FEV1) to forced vital 
capacity (FVC). By far the strongest risk factors for airflow obstruction are smoking and exposure to 
environmental tobacco smoke, but many areas of the world with high mortality rates from ‘COPD’ still have low 
consumption of tobacco. The distribution of death from COPD in the UK is not the same as that of lung cancer, 
the disease most strongly associated with tobacco consumption, but is more closely associated with low social 
status and poverty 5, 6.  
In recent years, anemia has become another comorbidity that has gained importance in patients with COPD. 
Traditional teaching in clinical medicine considers polycythemia to be a common adverse event of hypoxemia in 
COPD. However, nowadays this occurs less frequently due to more rigorous correction of hypoxemia by 
domiciliary long-term oxygen therapy. Conversely, anemia has been reported more frequently in association 
with COPD in recent years with an impact on the quality of life (QOL), healthcare utilization, and survival 7. 
Anemia in COPD ranges from 7.5 to 44 % as reported in different studies 
8-10
, Silverber reported frequency of 
anemia in 43.9 % 
9
 and Boutou et al 
10 
reported frequency of anemia is 10.24 % in patients with COPD. 
 
Material and Methods: 
A total of 142 patients having COPD were registered from Department of Medicine, Nishtar Hospital, Multan, 
Pakistan. Known cases with asthma, pulmonary embolus, lung cancer, sleep apnea, ischemic heart diseases, 
pregnant ladies and history of blood transfusion in last 6 months were excluded.  Venous blood sample was 
taken (3 ml) in EDTA vial and sent to central laboratory of Nishtar Hospital Multan, for estimation of Hb levels. 
History was taken like diabetes, hypertension and smoking  and other sociodemographic factors were inquired. 
Statistical analysis was performed by entering all the data in SPSS version 20.  
 
Results; 
Our study comprised of a total of 142 study cases with COPD who met inclusion criteria of our study. 
Of these 142 study cases, 94 (66.2%) were male patients while 48 (33.8%) were female patients. Mean age of 
our study cases was 54.68 ± 6.47 years (with minimum age of our study cases was 35 years while maximum age 
was 60 years). Mean age of the male patients was 55.86 ± 4.98 years while that of female patients was 52.38 ± 
8.27 years (p = 0.002). Our study results have indicated that majority of our study cases i.e. 116 (81.7%) were 
aged 46 – 60 years of age. Fifty seven (40.1%) were rural while 85 (59.9%) had urban residential background, 
116 (81.7%) were poor, 34 (23.9%) were diabetic and 45 (31.7%) were hypertensive. Mean height of our 
patients was 154.31 ± 11.12 centimeters while mean weight of our study cases was 65.21 ± 6.99 kilograms and 
mean body mass index was 24.08 ± 3.22 kg/m
2
. Our study results reported 87 (61.3 %) were normal weight, 33 
(23.2 %) were overweight and 22 (15.5 %) were obese. Smoking was noted in 70 (49.3%) of our study cases. 
Mean duration of illness was 26.32 ± 12.44 months and 92 (64.8%) had disease duration more than 18 months. 
Mean hemoglobin level of our patients was 11.14 ± 1.76 g/dL (Range; 9.4 g/dL to 14.5 g/dL) and anemia was 
present in 64 (45.1%) patients.  
Discussion;  
Systemic manifestations and comorbidities commonly reported in COPD include cardiovascular disease, 
malnutrition, osteoporosis, gastroesophageal reflux, and clinical depression and anxiety. In recent years, anemia 
has become another comorbidity that has gained importance in patients with COPD. Anemia has been reported 
more frequently in association with COPD in recent years with an impact on the quality of life (QOL), healthcare 
utilization, and survival 
11
.  
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Different studies in literature, have reported high male gender predominance. Similarly out of our 142 
study cases, 94 (66.2%) were male patients while 48 (33.8%) were female patients.  A study conducted by 
Waqas et al  12 from Islamabad also reported male gender predominance with 70 % male patients with COPD 
which is close to our study results. A study conducted in Karachi by Khan et al 
13 
also reported high male gender 
predominance with 80 % male patients. A study conducted by Ahmad et al 
 14 
from Peshawar has reported female 
gender preponderance which is different from our findings. Maula et al 
 15 
also reported 65.4 % male patients 
with COPD showing male gender predominance which is in compliance with our study results. 
Mean age of our study cases was 54.68 ± 6.47 years (with minimum age of our study cases was 35 
years while maximum age was 60 years). Mean age of the male patients was 55.86 ± 4.98 years while that of 
female patients was 52.38 ± 8.27 years (p = 0.002). Our study results have indicated that majority of our study 
cases i.e. 116 (81.7%) were aged 46 – 60 years of age. A study conducted by Ahmad et al  14 from Peshawar has 
reported 62 ± 13 years mean age of the patients having COPD which is slightly higher than our findings. A study 
conducted by Iftikhar et al 
 16 
 from Peshawar has also reported similar results. A study conducted by Maula et al 
15  
from Bannu has also reported 60.18 ± 11.67 years mean age which is close to our study results. Fifty seven 
(40.1%) were rural while 85 (59.9%) had urban residential background, 116 (81.7%) were poor, 34 (23.9%) 
were diabetic and 45 (31.7%) were hypertensive. A study conducted by Mahishale et al 17 also reported 21.24 % 
diabetes in patients with COPD which is close to our study results.  
Mean height of our patients was 154.31 ± 11.12 centimeters while mean weight of our study cases was 
65.21 ± 6.99 kilograms and mean body mass index was 24.08 ± 3.22 kg/m2. Our study results reported 87 (61.3 
%) were normal weight, 33 (23.2 %) were overweight and 22 (15.5 %) were obese. Smoking was noted in 70 
(49.3%) of our study cases. Mean duration of illness was 26.32 ± 12.44 months and 92 (64.8%) had disease 
duration more than 18 months. A study conducted by Ahmad et al 
 14  
from Peshawar has reported history of 
smoking was present in 37.5% which is in compliance with our study results. A study conducted by Iftikhar et al  
16 
 from Peshawar has also reported 38 % smoking which is close to our findings.  
Mean hemoglobin level of our patients was 11.14 ± 1.76 g/dL (Range; 9.4 g/dL to 14.5 g/dL) and 
anemia was present in 64 (45.1%) patients. Anemia in COPD ranges from 7.5 to 44 % as reported in different 
studies 8-10, Silverber reported frequency of anemia in 43.9 % 9 which is close to our study results. A study 
conducted by Shorr et al 
 18 
has reported 33 % anemia in patients with COPD which is in compliance with that of 
our study results.  
Conclusion; 
Very high frequency of anemia was noted in our study among patients having chronic obstructive 
pulmonary disease (COPD). Anemia was significantly associated with poor socio – economic status, obesity and 
prolonged disease duration. Clinicians who are treating these patients with COPD must check their hemoglobin 
levels regularly for better prognosis.  
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